Literature DB >> 29700556

Diagnostic value of novel biomarkers for heart failure : A meta-analysis.

Z Huang1, J Zhong2, Y Ling1, Y Zhang1, W Lin1, L Tang1, J Liu1, S Li3.   

Abstract

BACKGROUND: The present meta-analysis examined the diagnostic value of novel biomarkers for heart failure (HF), including copeptin, galectin-3, hs-cTnT, MR-proANP, MR-proADM, and ST2.
METHODS: English (EMBASE, Cochrane, and PubMed) and Chinese (Wanfang data, CNKI, SinoMed) databases were searched to identify suitable studies that were published before 1 December 2016. Data were extracted using standard forms. Pooled diagnostic statistics were calculated using DerSimonian-Laird random-effects models.
RESULTS: The analysis comprised 45 studies. The pooled sensitivities of all biomarkers were 0.80-0.86, along with pooled specificities of 0.60-0.82, positive predictive values (PPVs) of 0.52-0.80, and negative predictive values (NPVs) of 0.70-0.87. Among them, hs-cTnT had the highest sensitivity (0.86 [95% CI: 0.84-0.88]), specificity (0.82 [95% CI: 0.79-0.84]), PPV (0.80 [95% CI: 0.77-0.83]), and NPV (0.87 [95% CI: 0.85-0.89]), while MR-proADM had the lowest sensitivity (0.80 [95% CI: 0.75-0.84]), specificity (0.60 [95% CI: 0.56-0.64]), and PPV (0.52 [95% CI: 0.47-0.56]). Copeptin had the lowest NPV (0.70 [95% CI: 0.66-0.74]). The positive likelihood ratio (LR+) of all biomarkers ranged from 1.97 to 3.21, and the negative likelihood ratio (LR-) from 0.20 to 0.36. MR-proADM had the lowest LR+ and highest LR-; galectin-3 had the highest LR+ and MR-proANP had the lowest LR-. The area under the curve (AUC) was as low as 0.68 for MR-proADM, while AUCs for the other biomarkers ranged from 0.83 to 0.89.
CONCLUSION: The overall diagnostic accuracy of copeptin, galectin-3, hs-cTnT, MR-proANP, and ST2 was relatively good. MR-proADM had a poor capacity to confirm or exclude HF. Improving the diagnostic accuracy of HF by a combination of biomarkers could be considered in the future.

Entities:  

Keywords:  Biologic marker; Diagnosis; Diastolic heart failure; Heart disease; Sensitivity and specificity

Mesh:

Substances:

Year:  2018        PMID: 29700556     DOI: 10.1007/s00059-018-4702-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  66 in total

1.  Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction.

Authors:  Elif Elmas; Siegfried Lang; Carl Erik Dempfle; Thorsten Kälsch; Jana Papassotiriou; Nils G Morgenthaler; Martin Borggrefe; Martina Brueckmann
Journal:  Int J Cardiol       Date:  2007-08-14       Impact factor: 4.164

2.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Effects of prehospital medications on mortality and length of stay in congestive heart failure.

Authors:  R C Wuerz; S A Meador
Journal:  Ann Emerg Med       Date:  1992-06       Impact factor: 5.721

Review 4.  Novel biomarkers in acute heart failure: MR-pro-adrenomedullin.

Authors:  W Frank Peacock
Journal:  Clin Chem Lab Med       Date:  2014-10       Impact factor: 3.694

5.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis
Journal:  Circulation       Date:  2012-08-24       Impact factor: 29.690

6.  High-sensitive troponin-T in adult congenital heart disease.

Authors:  Jannet A Eindhoven; Jolien W Roos-Hesselink; Annemien E van den Bosch; Isabella Kardys; Jin M Cheng; Jesse F Veenis; Judith A A E Cuypers; Maarten Witsenburg; Ron H N van Schaik; Eric Boersma
Journal:  Int J Cardiol       Date:  2015-02-25       Impact factor: 4.164

7.  Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.

Authors:  Camille Chenevier-Gobeaux; Sylvie Guerin; Stéphanie André; Patrick Ray; Luc Cynober; Stéphanie Gestin; Jean-Louis Pourriat; Yann-Erick Claessens
Journal:  Clin Chem       Date:  2010-09-02       Impact factor: 8.327

Review 8.  Does this dyspneic patient in the emergency department have congestive heart failure?

Authors:  Charlie S Wang; J Mark FitzGerald; Michael Schulzer; Edwin Mak; Najib T Ayas
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

9.  Soluble ST2 serum concentration and renal function in heart failure.

Authors:  Antoni Bayes-Genis; Elisabet Zamora; Marta de Antonio; Amparo Galán; Joan Vila; Agustín Urrutia; Crisanto Díez; Ramon Coll; Salvador Altimir; Josep Lupón
Journal:  J Card Fail       Date:  2013-11       Impact factor: 5.712

10.  Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).

Authors:  Mark Richards; Salvatore Di Somma; Christian Mueller; Richard Nowak; W Frank Peacock; Piotr Ponikowski; Martin Mockel; Christopher Hogan; Alan H B Wu; Paul Clopton; Gerasimos S Filippatos; Inder Anand; Leong Ng; Lori B Daniels; Sean-Xavier Neath; Kevin Shah; Robert Christenson; Oliver Hartmann; Stefan D Anker; Alan Maisel
Journal:  JACC Heart Fail       Date:  2013-06-03       Impact factor: 12.035

View more
  7 in total

Review 1.  β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.

Authors:  Xiao-Jun Du; Wei-Bo Zhao; My-Nhan Nguyen; Qun Lu; Helen Kiriazis
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

Review 2.  Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.

Authors:  Danni Mu; Jin Cheng; Ling Qiu; Xinqi Cheng
Journal:  Front Cardiovasc Med       Date:  2022-07-04

3.  Suppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduced ejection fraction.

Authors:  Lindsey Aurora; Edward Peterson; Hongsheng Gui; Nicole Zeld; James McCord; Yigal Pinto; Bernard Cook; Hani N Sabbah; L Keoki Williams; James Snider; David E Lanfear
Journal:  Clin Chim Acta       Date:  2020-09-12       Impact factor: 3.786

4.  Endocrine system dysfunction and chronic heart failure: a clinical perspective.

Authors:  Giuseppe Lisco; Vito Angelo Giagulli; Michele Iovino; Roberta Zupo; Edoardo Guastamacchia; Giovanni De Pergola; Massimo Iacoviello; Vincenzo Triggiani
Journal:  Endocrine       Date:  2021-10-28       Impact factor: 3.925

5.  Galectins for Diagnosis and Prognostic Assessment of Human Diseases: An Overview of Meta-Analyses.

Authors:  Yiting Liu; Hao Meng; Shixue Xu; Xingshun Qi
Journal:  Med Sci Monit       Date:  2020-08-03

6.  Role of the IL-33/ST2 axis in cardiovascular disease: A systematic review and meta-analysis.

Authors:  Yuan Sun; Holly Pavey; Ian Wilkinson; Marie Fisk
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

7.  Inflammatory markers and incident heart failure in older men: the role of NT-proBNP.

Authors:  Douglas Gj McKechnie; A Olia Papacosta; Lucy T Lennon; Paul Welsh; Peter H Whincup; S Goya Wannamethee
Journal:  Biomark Med       Date:  2021-03-12       Impact factor: 2.851

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.